JAMP India Pharmaceuticals Walk-In Interview  for Regulatory Affairs | Multiple Openings | Ahmedabad

JAMP India Pharmaceuticals Pvt. Ltd. has announced a Walk-In Interview for experienced and fresh pharmaceutical professionals in the Regulatory Affairs Department. The company is hiring for multiple positions in CMC Canada and eCTD functions for Canada, Australia, New Zealand, UK, and Europe markets. Candidates with B.Pharm or M.Pharm qualifications are invited to attend the interview.

Organization Details

Company: JAMP India Pharmaceuticals Pvt. Ltd.

Department: Regulatory Affairs

Job Location: Ahmedabad, Gujarat

Interview Type: Walk-In Interview

Walk-In Interview Details

Interview Date: Sunday, 5 July 2026

Time: 10:00 AM – 4:00 PM

Venue:

JAMP India Pharmaceuticals Pvt. Ltd.

A-1207, 12th Floor, Navratna Corporate Park,

Ambli Bopal Road, Ambli, Ahmedabad – 380058

Available Positions

1. Regulatory Affairs – CMC Canada (2 Positions)

Designation:

Manager

Deputy Manager

Assistant Manager

Qualification:

B.Pharm / M.Pharm

Experience:

7–12 Years

Mandatory Market Experience:

Canada

USA

Europe

Australia

New Zealand

Key Responsibilities

Review and finalize new drug submissions.

Handle regulatory deficiency responses.

Prepare Quality Overall Summary (QOS).

Conduct dossier due diligence.

Lead and mentor Regulatory Affairs teams.

Coordinate with cross-functional departments.

Support post-approval regulatory activities.

2. Regulatory Affairs – CMC Canada (5 Positions)

Designation:

Senior Executive

Executive

Qualification:

B.Pharm / M.Pharm

Experience:

7–9 Years

Mandatory Market Experience:

Canada

USA

Europe

Australia

New Zealand

Responsibilities

Compile and submit ANDS dossiers.

Prepare Health Canada and Australia deficiency responses.

Coordinate with Analytical and Formulation Development teams.

Ensure GMP compliance.

Provide regulatory support across departments.

3. Regulatory Affairs – CMC Canada (4 Positions)

Designation:

Trainee Officer

Qualification:

B.Pharm / M.Pharm

Preferred Specialization:

Regulatory Affairs

Pharmaceutics

Eligibility

Freshers with internship in Regulatory Affairs are preferred.

Responsibilities

ANDS compilation and submission.

Documentation review.

Deficiency response preparation.

Cross-functional coordination.

Regulatory training and compliance.

4. Regulatory Affairs – eCTD (1 Position)

Designation:

Senior Officer

Officer

Trainee Officer

Qualification:

B.Pharm / M.Pharm

Experience:

0–3 Years

Eligibility:

Freshers can apply.

Mandatory Market Exposure:

Canada

USA

Europe

Australia

New Zealand

Responsibilities

eCTD compilation and validation.

Electronic submission through ESG Gateway.

ANDS/NDS submissions.

Prepare deficiency responses (Clarifax, SDN, NOD, NON, etc.).

Lifecycle management of regulatory dossiers.

Submission tracking and document maintenance.

Documents Required

Candidates should carry:

Updated Resume

Passport-size Photograph

Last 3 Months Salary Slips (if applicable)

Current Appointment Letter

Important Instructions

Candidates interviewed within the last 30 days are not eligible to apply again.

JAMP India does not charge any recruitment or registration fee.

Candidates unable to attend the walk-in interview may email their updated resume to hrindia@jamppharma.com or apply using the QR code provided in the official notification.

Why Join JAMP India?

International Regulatory Affairs exposure.

Opportunities across Canada, US, EU, Australia, and New Zealand markets.

Career growth in CMC and eCTD regulatory functions.

Professional learning in global pharmaceutical compliance.

Work with experienced regulatory professionals.

Technical FAQs

1. What is an ANDS submission?

ANDS (Abbreviated New Drug Submission) is a regulatory application submitted to Health Canada for approval of generic pharmaceutical products, demonstrating bioequivalence and quality compliance.

2. What is eCTD in Regulatory Affairs?

eCTD (Electronic Common Technical Document) is the globally accepted electronic format used for preparing, validating, and submitting regulatory dossiers to health authorities such as Health Canada, US FDA, EMA, and TGA.

3. What is the Quality Overall Summary (QOS)?

The Quality Overall Summary (QOS) provides a concise summary of pharmaceutical quality information, including manufacturing, stability, specifications, and control strategies for regulatory review.

4. What are regulatory deficiency responses?

Deficiency responses are formal replies submitted to regulatory authorities addressing questions or observations raised during the review of a drug application. Accurate documentation and scientific justification are essential.

5. What is ESG Gateway in pharmaceutical submissions?

The Electronic Submission Gateway (ESG) is a secure platform used by regulatory authorities to receive electronic regulatory submissions, including eCTD applications, amendments, and lifecycle updates.